B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

KCNMB1

MOLECULAR TARGET

potassium calcium-activated channel subfamily M regulatory beta subunit 1

UniProt: Q16558NCBI Gene: 377932 compounds

KCNMB1 (potassium calcium-activated channel subfamily M regulatory beta subunit 1) is targeted by 32 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting KCNMB1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Budesonide1.102
2pterostilbene1.102
3Resveratrol1.102
4Carvedilol1.102
5Ethylestrenol1.102
6Ezetimibe1.102
7Fluocinolone Acetonide1.102
8Glyburide1.102
9Irbesartan1.102
10Latanoprost1.102
11Nisoldipine1.102
12Oxaprozin1.102
13Promethazine1.102
14Thioridazine1.102
15Thyroxine0.691
16Simvastatin0.691
17Amoxapine0.691
18Calcitriol0.691
19Chlorpheniramine0.691
20Desoximetasone0.691
21Disulfiram0.691
22Etodolac0.691
23Levonorgestrel0.691
24nafadotride0.691
253',4'-didemethylnobiletin [Supplementary Concept]0.691
26Norgestrel0.691
27Nortriptyline0.691
28Oxcarbazepine0.691
29Perphenazine0.691
30Ritonavir0.691
31Thyroxine0.691
32Ursodeoxycholic Acid0.691

About KCNMB1 as a Drug Target

KCNMB1 (potassium calcium-activated channel subfamily M regulatory beta subunit 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 32 compounds with documented KCNMB1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

KCNMB1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.